Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.
종목 코드 SNY
회사 이름Sanofi SA
상장일Jul 01, 2002
CEOHudson (Paul)
직원 수84587
유형Depository Receipt
회계 연도 종료Jul 01
주소46 Avenue de la Grande Armee
도시PARIS
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가France
우편 번호75017
전화33153774000
웹사이트https://www.sanofi.com/
종목 코드 SNY
상장일Jul 01, 2002
CEOHudson (Paul)